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Abstract:  25 
Many species of tsetse flies (Diptera: Glossinidae) can be infected by a virus that causes 26 
salivary gland hypertrophy (SGH). The genomes of viruses isolated from Glossina 27 
pallidipes (GpSGHV) and Musca domestica (MdSGHV) have recently been sequenced. 28 
Tsetse flies with SGH have a reduced fecundity and fertility which cause a serious 29 
problem for mass rearing in the frame of sterile insect technique (SIT) programs to 30 
control and eradicate tsetse populations in the wild. A potential intervention strategy to 31 
mitigate viral infections in fly colonies is neutralizing of the GpSGHV infection with 32 
specific antibodies against virion proteins. Two major GpSGHV virion proteins of about 33 
130 kDa and 50 kDa, respectively, were identified by Western analysis using polyclonal 34 
rabbit antibody raised against whole GpSHGV virions. The proteome of GpSGHV, 35 
containing the antigens responsible for the immune-response, was investigated by liquid 36 
chromatography tandem mass spectrometry (LC-MS/MS) and 61 virion proteins were 37 
identified by comparison with the genome sequence. Specific antibodies were produced 38 
in rabbits against seven candidate proteins including the ORF10 / C-terminal fragment, 39 
ORF47 and ORF96 as well as proteins involved in peroral infectivity PIF-1 (ORF102), 40 
PIF-2 (ORF53), PIF-3 (ORF76) and P74 (ORF1). Antiserum against ORF10 specifically 41 
reacted to the 130 kDa protein in a Western blot analysis and to the envelope of 42 
GpSGHV using immunogold-EM. This result suggests that immune intervention of viral 43 
infections in colonies of G. pallidipes is a realistic option. 44 
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INTRODUCTION 45 
Tsetse flies (Diptera: Glossinidae) are the vectors of sleeping sickness in humans (or 46 
human African trypanosomosis, HAT) and the livestock disease nagana (or African 47 
animal trypanosomosis, AAT) (Steelman, 1976; WHO, 2001). The continuing presence 48 
and advancement of tsetse flies prevents the development of sustainable and profitable 49 
livestock production systems, thus greatly influencing food production, natural-resource 50 
utilization and human settlement in almost two thirds of sub-Sahara Africa (Jordan, 51 
1986). There are no effective vaccines against trypanosomosis and the disease is mainly 52 
managed by the prophylactic and curative treatment with trypanocidal drugs. However, 53 
there have been reports of development of resistance to the available trypanocidal drugs 54 
(Aksoy & Rio, 2005). It is generally accepted that vector control remains the most 55 
effective way of managing the disease and the sterile insect technique (SIT) that relies on 56 
the sequential release of sterile male flies in the wild has proven to be a robust technique 57 
for use in an area-wide integrated pest management (AW-IPM) approach (Hendrichs et 58 
al., 2007; Vreysen et al., 2000). Upon mating of the sterile males with virgin female wild 59 
flies there is no offspring which leads to a reduction in tsetse fly population density. 60 
Glossina austeni has been successfully eradicated from the Island of Unguja, United 61 
Republic of Tanzania using insecticide impregnated targets, insecticide “pour on” on 62 
livestock and the release of sterile insects, and efforts are being made to do the same in 63 
the Southern Rift Valley of Ethiopia (Feldmann, 2005). 64 
Sterile males for AW-IPM programmes with an SIT component are produced in 65 
mass rearing facilities and sterilized with ionizing radiation (usually 60Co or 137Ce). 66 
However, the production of Glossina pallidipes flies is hampered by the fact that the fly 67 
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colonies are contaminated by a Salivary Gland Hypertrophy Virus (GpSGHV) (Ellis and 68 
Maudlin, 1987; Jaenson, 1978 (Jura et al., 1988; Jura et al., 1989) which affects the 69 
productivity and fecundity of these colonies. The low productivity of these colonies 70 
makes the rearing very cumbersome and often leads to colony collapse. 71 
GpSGHV is a rod-shaped, double-stranded, circular double-stranded DNA virus 72 
with a genome of 190 kilobase (kb) pairs and averaging 70 x 640 nm in size (Fig. 1) 73 
(Abd-Alla et al., 2008; Odindo et al., 1986). The presence of the virus in the salivary 74 
glands of male and female flies explains the hypertrophied appearance (hyperplasia) of 75 
these glands. The virus has also been associated with testicular degeneration and ovarian 76 
abnormalities (Kokwaro et al., 1990; Sang et al., 1998; Sang et al., 1999). Although it is 77 
not yet clear how the fly gets infected with the virus and how exactly the virus affects the 78 
mating and feeding behavior of the fly, it has been demonstrated recently that in mass 79 
rearing facilities the virus is released from the infected fly with saliva upon blood 80 
ingestion and transmitted through the blood to other flies (Abd-Alla et al., 2010). In 81 
nature, the virus is likely transmitted vertically from mother to offspring, either trans-82 
ovum or through infected milk glands (Jura et al., 1989; Sang et al., 1998; Sang et al., 83 
1996) and the infection is largely asymptomatic. Similar viruses have been described 84 
from the bulb fly Merodon equestris (Amargier et al., 1979) and the house fly Musca 85 
domestica (Coler et al., 1993). 86 
The entire GpSGHV genome has been sequenced (Abd-Alla et al., 2008) and 160 87 
open reading frames (ORF) have been identified. Putative functions could be assigned to 88 
only very few ORFs by blasting against databases. Most notable is the presence of 89 
homologues of the per os infectivity factor (PIF) genes of baculoviruses. These factors 90 
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are involved in the oral transmission of baculoviruses from insect to insect. Their 91 
presence in GpSGHV suggests a similar mechanism of infection, which is in fact 92 
compatible with GpSGHV transmission via the blood meal. 93 
One strategy to control the GpSGHV infections of G. pallipides flies in mass-94 
rearing facilities is to prevent horizontal GpSGHV transmission by immune-complexing 95 
the virus in the blood meal and/or in the saliva. In this paper, we report the proteomic 96 
analysis of the GpSGHV proteome and the identification of the immune-responsive, 97 
virus-encoded proteins for development of antibodies to be used in immune intervention 98 
in order to prevent SGHV infections in G. pallidipes colonies. 99 
 100 
RESULTS AND DISCUSSION 101 
 102 
Analysis of the GpSGHV proteome 103 
The recent sequencing of the Uganda isolate of GpSGHV (Abd-Alla et al., 2008; Abd-104 
Alla et al., 2009) has provided information that greatly facilitated the assignment of 105 
ORFs for virion proteins on the genome. The major disadvantage in our study is the lack 106 
of a cell culture system for the production of GpSGHV virions which made it rather 107 
difficult to purify a large amount of GpSGHV virions with high quality. GpSGHV virions 108 
were therefore, purified from hypertrophied salivary gland cells dissected from infected 109 
tsetse flies. In addition, to minimize the disadvantage of losing the envelope protein as 110 
observed after purification of GpSGHV using sucrose gradients previously (Abd-Alla et 111 
al., 2007), the virus particles were purified over a nycodenz-gradient, resulting in only a 112 
single viral band at a density of 1.153g cm-3 (Fig. 1A). The integrity of the virions after 113 
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Nycodenz purification was checked by the transmission electron microscopy, but they 114 
appeared to be fragile (Fig. 1B and C). It is possible that some host proteins have been 115 
co-purified, but also that they are intricately associated with virions, such as actin (Lanier 116 
& Volkman, 1998; Wang et al., 2010).  Separation of the purified GpSGHV proteins by 117 
gradient SDS-PAGE revealed at least 35 proteins ranging in size from 10 kDa to > 130 118 
kDa (Fig. 2A). The most abundant proteins run at about 43 to 50 kDa (multiple bands) 119 
and 130 kDa.  120 
The gel lane was divided into 7 slices containing proteins with a molecular mass 121 
ranging from lower than 26 kDa, 26-34 kDa, 34-43 kDa, 43-55 kDa, 55-95 kDa, 95-130 122 
kDa to > 130 kDa, respectively (Fig. 2B) and protein extracts of each of the slices were 123 
subjected to LC/MSMS analysis. A decoy database strategy was used (Elias & Gygi, 124 
2007) which, after applying the appropriate filters, resulted in 90 protein hits: 61 viral 125 
proteins, 28 contaminants and 1 decoy hit giving a False Discovery Rate of 1.1%. The 126 
LC-MS/MS method allowed the detection of GpSGHV proteins that were present in 127 
relatively low quantities. Fifty seven GpSGHV proteins were identified with 2 or more 128 
peptides (Table 1). Manual verification of the 4 peptides with a single identified peptide 129 
not only revealed a sufficient overlap between virtual and measured MS/MS spectra but 130 
also showed that no other peptides present in the database can explain the measured 131 
spectra.  132 
The ORFs corresponding to 61 virion proteins were superposed on the physical 133 
map of GpSGHV (Fig. 3). The virion protein genes were almost equally distributed over 134 
both strands of the genome. Within the genome two segments encoding ORF11 to 26 and 135 
ORF114 to 139 were devoid of virion protein genes. In contrast, other segments (ORF78 136 
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to 113) were densely populated with virion protein genes (22 out of 29 = 76%). Also 137 
ORF62, a giant ORF was identified as encoding a constituent of GpSGHV virions 138 
representing a protein of about 511 kDa. Such a large virion protein is not unusual for 139 
large double stranded DNA viruses, as white spot syndrome virus has a 664 kDa virion 140 
protein which is a major nucleocapsid protein (van Hulten et al., 2001; Leu et al., 2005). 141 
Whereas the 511 kDa protein is probably a minor component (1.8% peptide coverage), 142 
another large protein of 127 kDa (ORF10) was found in high abundance (with 16.9% 143 
coverage) and probably represents the 130 kDa protein seen in SDS-PAGE (Fig. 2A). 144 
 145 
Gene homology and domains analyses 146 
Homology searches with the identified GpSGHV proteins performed against 147 
GeneBank/EMBL, Swisprot, and PIR databases, revealed that of the 61 proteins 148 
identified, 4 were unique to GpSGHV (encoded by ORFs 2, 39, 47 and 49). Neither the 149 
nucleotide sequences nor the deduced protein sequences of these genes shared significant 150 
homology to other genes/proteins identified so far. In addition, among the GpSGHV 151 
proteins identified by LC-MS/MS, five proteins had homologs in baculoviruses and 152 
nudiviruses (ORFs 1, 53, 76, 102 and 110) and one had homology to a nimavirus ORF 153 
(ORF36) (Table 1).  154 
Among the GpSGHV virion proteins identified (Table 1) there are homologs of 155 
all four baculovirus per os infectivity factors (PIF-1, PIF-2, PIF-3 and PIF-0/P74). These 156 
factors, encoded by ORFs 1, 53, 76 and 102, are thought to be involved in the oral 157 
infection process of baculovirus occlusion derived virions by binding to midgut epithelial 158 
cells (Slack & Arif, 2007). PIF-1, PIF-2, and P74 have been shown to mediate specific 159 
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binding of ODVs to midgut cells suggesting that they are directly involved in the virus 160 
host cell interaction at an initial step in infection (Ohkawa et al., 2005; Kikhno et al., 161 
2002; Slack et al., 2010). Although PIF-3 appears to be an ODV-associated protein (Li et 162 
al., 2007), it does not appear to be involved in specific binding and its function is not 163 
known yet. The PIF proteins are absolutely essential for baculovirus oral infectivity 164 
(Kuzio et al., 1989; Kikhno et al., 2002; Pijlman et al., 2003; Song et al., 2008; Slack et. 165 
al., 2010; Peng et al., 2010). The presence of these PIF proteins in the GpSGHV 166 
proteome is a strong indication that they might have a similar function in GpSGHV 167 
infection following uptake via a blood meal. 168 
 169 
Comparative proteomics of GpSGHV and MdSGHV 170 
Recently a limited proteomic analysis has been carried out for an SGHV from the house 171 
fly Musca domestica (MdSGHV), the genome of which is also entirely sequenced 172 
(Garcia-Maruniak et al., 2008). This virus is highly related to GpSGHV and is proposed 173 
to be accommodated in a newly proposed virus family Hytrosaviridae (Garcia-Maruniak 174 
et al., 2009; Abd-Alla et al., 2009).  GpSGHV has 42 ORFs with homologs in MdSGHV 175 
(Garcia-Maruniak et al., 2009). Comparative analysis of the GpSGHV virion proteins 176 
with all MdSGHV ORFs (Garcia-Maruniak et al., 2008) showed that 33 out of the 61 177 
identified GpSGHV virion proteins were homologous to 28 MdSGHV ORFs (Table 2). 178 
The difference in ORF numbers (32 compared to 28) follows from the notion that four 179 
MsSGHV ORFs have pairs of homologs in GpSGHV (see below). Of the 28 MdGSHV 180 
ORFs homologous to the GpSGHV proteome ORFs, only 12 were actually identified in 181 
the MdSGHV proteome (Garcia et al., 2008). 182 
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The homology of the virion proteins and the presence of a number of proteins 183 
shared between GpSGHV and MdSGHV virions suggests that the two viruses have 184 
further properties in common, such as their virion structure and assembly mechanisms 185 
and give further credence to the presence of a common ancestor of these two viruses 186 
(Abd-Alla et al., 2009). The notion that out of four putative SGHV per os infectivity 187 
factors only P74 was identified in the MdSGHV virion, but not PIF-1, 2 and 3, may 188 
suggest that some virion proteins may have been missed in the MdSGHV analysis 189 
(Garcia-Maruniak et al., 2008). 190 
The comparative proteomics of GpSGHV and MdSGHV showed four instances of 191 
gene duplications in GpSGHV (Table 2). GpSGHV ORF30 (133 aa) and ORF31 (285 aa) 192 
are both homologous to MdSGHV ORF82 (359 aa). The GpSGHV ORFs ORF32/33, 193 
ORF96/97 and ORF107/108 are homologous to MdSGHV ORFs 74, 25 and 33, 194 
respectively. Gene duplication is one important mechanism by which large DNA viruses 195 
increase their genome size and is a major mechanism for the acquisition of new gene 196 
functions (Long et al., 2001). ORF107 and ORF108 were shown before to be the likely 197 
result of gene duplication (Garcia-Maruniak et al., 2009). On the other hand, in 2 of the 4 198 
cases (GpSGHV ORF30/31 and ORF32/33) the two GpSGHV ORFs in these pairs are 199 
homologous to different parts of the corresponding MdSGHV ORF and show no 200 
significant mutual homology within the pairs. Hence, these pairs are most likely the 201 
consequence of extra stop codons in GpSGHV or, alternatively, the result of sequencing 202 
artifacts. For ORF96 and ORF97 the situation is less clear as these ORFs show mutual 203 
similarities over 276 amino acids, but only for 41% and only when several gaps are 204 
introduced. In addition GpSGHV ORF110 has a homolog in ORF111 as a result of gene 205 
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duplication (Garcia-Maruniak et al., 2009), but in the current analysis only peptides 206 
derived from ORF110 were detected. 207 
 208 
Identification of immunodominant proteins 209 
To identify those GpSGHV virion proteins that give an immune response in rabbits, 210 
antiserum was raised against purified GpSGHV virions and tested against GpSGHV 211 
proteins in a Western analysis (Fig. 4). The antiserum reacted with several GpSGHV 212 
proteins, more specifically to a 130 kDa protein, to proteins in the 50 kDa range and to an 213 
array of proteins in the 30 kDa range. On the basis of the proteomic LC-MS/MS and the 214 
Western analyses (Table 1 and Fig. 4) ORF10 (approximately 127 kDa) and six ORFs 215 
with molecular sizes ranging between 43-50 kDa (ORFs 41, 47, 70, 96, 97 and 140) were 216 
tested as candidates for the observed immunodominant proteins in GpSGHV (Fig. 4). 217 
These ORFs were expressed in E. coli BL21 cells. Due to its large size, ORF10 was split 218 
into two fragments (N- and C- terminal fragments with calculated molecular sizes of 219 
approximately 69 kDa and 66 kDa, respectively). In addition, due to their assumed 220 
important role in oral infectivity and potential target for immune intervention, all the four 221 
PIF genes were selected as candidates for protein expression in bacteria. ORF1 (p74), 222 
ORF41, ORF70, ORF97 and the N-terminal fragment of ORF10 could not be 223 
successfully expressed in E. coli. Of the six proteins that were successfully made and that 224 
reacted with the rabbit antiserum against GpSGHV virions (PIF-1, PIF-2, PIF-3, ORF47, 225 
ORF96 and the C-terminal fragment of ORF10), two ORFs, ORF10 (C-terminal) and 226 
ORF96, were selected to generate mono-specific polyclonal antibodies based on the fact 227 
that these two ORFs were found to be the major viral proteins (Table 1). Antibodies 228 
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raised against the proteins encoded by ORF10 (C-terminal) and ORF96 were tested 229 
against GpSGHV and homogenates of hypertrophied salivary glands of infected G. 230 
pallipides flies (Fig. 5A). As expected these antibodies reacted against the 130 kDa and 231 
50 kDa band, respectively. 232 
 233 
Immunolocalization of SGHV proteins 234 
Transmission electron microscopy (TEM) using the antibody against the C-terminal 235 
fragment of ORF10 gave an indication that the protein is likely to be a component of the 236 
envelope of the virus (Fig. 5B-b). Immunolocalization studies of ORF96 using the 237 
specific rabbit antibody against this protein did not give conclusive evidence whether this 238 
protein is part of the virus envelope as there were no gold particles observed on the 239 
virions under the conditions used in the TEM studies. This could mean that either the 240 
ORF96 protein could have hidden epitopes or the antiserum was not suited for immuno 241 
EM. Furthermore it could be seen in the TEM that only a few GpSGHV virion rods 242 
remained entirely intact after Nycodenz-preparation. This confirms the fragile nature of 243 
GpSGHV virus and further work need to be done to study its stability under different 244 
conditions such as temperature, and especially the effects of virus handling on its 245 
infectivity to the tsetse fly. It is to be noted that a high density of gold particles were 246 
observed when antiserum against ORF10 was used, most likely on debris of the viral 247 
envelope. In the control experiments (preimmune serum), no gold particles could be seen 248 
for either the GpSGHV virion or the nucleocapsid. These studies may be direct evidence 249 
that the ORF10 could be involved functionally in the formation and/or the assembly of 250 
the GpSGHV envelope. 251 
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 252 
CONCLUDING REMARKS 253 
Current proteomic analysis of GpSGHV allowed us to determine a total of 61 proteins. 254 
The identities of the proteins within the virion proteome revealed many candidates which 255 
provide a basis for further studies focussing on the virulence and pathogenesis of 256 
GpSGHV as well as on mechanisms of virus infection and transmission in tsetse flies. 257 
Comparison of the 61 identified GpSGHV ORFs with double-stranded DNA viruses of 258 
other virus families showed only a few homologies (5), more specifically with 259 
baculoviruses and nudiviruses. These involve the PIF proteins that are essential for oral 260 
infectivity of baculoviruses in insects. Whether they are also functional PIF proteins, 261 
remains to be investigated. The proteomic data also clearly indicated that GpSGHV has a 262 
total of 32 structural ORFs that encode proteins not encoded in MdSGHV. Twenty-nine 263 
GpSGHV ORFs have homologs in MdSGHV, and so far twelve of these have also been 264 
identified in the MdSGHV proteome. In addition MdSGHV has a number of virion 265 
proteins that do not have homologs in GpSGHV. Therefore, this analysis further supports 266 
the placement of these two members of the newly-proposed Hytrosaviridae family in two 267 
separate genera (proposed names Glossinavirus and Muscavirus) (Abd-Alla et al., 2009). 268 
The role of these virion proteins in virion structure and infectivity will be the subject of 269 
future investigations. 270 
Proteomic and immunolocalization data indicated that the ORF10 protein is 271 
abundant and present on the virion envelope. In the light of these findings, the ORF10 272 
protein would be a good target for studies to mitigate infections of tsetse colonies by the 273 
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SGHV. The approach would be to supplement the blood meal with the ORF10 antibody 274 
or by immunizing cattle who are the blood donors in tsetse fly rearing systems. 275 
 276 
MATERIAL AND METHODS 277 
 278 
Preparation of virus particles and analysis by LC-MS/MS 279 
GpSGHV virions were purified from hypertrophied salivary glands collected from 280 
a G. pallidipes colony maintained at the Entomology Unit of the FAO/IAEA Agriculture 281 
& Biotechnology Laboratory, Seibersdorf, Austria. Hypertrophied salivary glands were 282 
collected from dissected flies, homogenized in Tris buffer (50 mM, pH 7.8), and clarified 283 
twice by centrifugation for 10 min at 3000 g. The supernatant was layered on a 10-60% 284 
linear Nycodenz gradient and centrifuged for 1h at 27,000 g. The viral band was taken 285 
and washed in Tris buffer and centrifuged for 1h at 150,000 g. The viral pellet was 286 
resuspended in Tris buffer.  287 
The purified virus particles were solubilized in 2x concentrated Laemmli buffer, 288 
and fractionated by SDS-PAGE (12%). Fermentas PageRuler Prestained Marker proteins 289 
were used. The gel was stained with colloidal blue and the gel lane containing the virion 290 
proteins was excised into seven contiguous sections spanning the complete gel lane based 291 
on a comparison with molecular markers.  292 
In-gel protein digestions and peptide extractions were performed at 25°C according to a 293 
method described (Ince et al., 2010). The peptides resulting from this digestion were 294 
analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS) by injecting 295 
18 µl of sample on a 0.10 x 32-mm Prontosil 300-5-C18H pre-concentration column 296 
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(Bischoff, Germany) at a flow of 6 µl/min for 5 min. Peptides were eluted from the pre-297 
concentration column onto a 0.10 x 200-mm Prontosil analytical column 300-3-C18H 298 
(Bischoff) with an acetonitrile (ACN; HPLC grade) gradient at a flow of 0.5 µl/min for 299 
50 min. The gradient consisted of 10 to 35% (v/v) acetonitril increased in water with 300 
1 ml/L formic acid in 50 min. As a subsequent cleaning step, the ACN concentration was 301 
increased to 80% (v/v) in 3 min (with 20% water and 1 ml/L formic acid in both the ACN 302 
and the water). Between the pre-concentration and analytical column, an electrospray 303 
potential of 3.5 kV was applied directly to the eluent via a solid 0.5 mm platina electrode 304 
fitted into a P875 Upchurch microT. Full scan positive mode Fourier transform mass 305 
spectra (FTMS) were measured between mass-to-charge ratios of 380 and 1400 with a 306 
LTQ-Orbitrap spectrometer (Thermo electron, San Jose, CA, USA).  307 
Tandem mass spectrometry (MS/MS) scans of the four most abundant doubly and 308 
triply charged peaks in the FTMS scan were recorded in a data dependent mode in the 309 
linear trap (MS/MS threshold = 10.000).  All MS/MS spectra obtained with each run 310 
were analyzed with Bioworks 3.1.1 software (Thermo Fisher Scientific, Inc.). A 311 
maximum of a single differential modification allowed per peptide was set for oxidation 312 
of methionines and de-amidation of asparagine and glutamine residues. 313 
Carboxamidomethylation of cysteines was set as a fixed modification. Trypsin specificity 314 
was set to fully enzymatic and a maximum of 3 missed cleavages with monoisotopic 315 
precursor and fragment ions. The mass tolerance for peptide precursor ions was set to 10 316 
parts per million and for MS/MS fragment ions to 0.5 Da.  317 
A Glossina pallidipes salivary gland hypertrophy virus protein database was used 318 
for the analysis (EF568108; created February 25, 2008; downloaded from 319 
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www.ncbi.nlm.nih.gov/sites/entrez) after adding a list of commonly observed 320 
contaminants like: BSA (P02769, bovine serum albumin precursor), trypsin (P00760, 321 
bovine), trypsin (P00761, porcin), keratin K22E (P35908, human), keratin K1C9 322 
(P35527, human), keratin K2C1 (P04264, human) and keratin K1CI (P35527, human). A 323 
decoy database was created by adding the reversed sequences using the program 324 
SequenceReverser from the MaxQuant package (Cox et al., 2008).  325 
To identify the proteins in the GpSGHV virions, the spectra obtained from the 326 
LC-MS/MS were searched against the GpSGHV ORF database using Bioworks 3.3.1. 327 
The peptide identifications obtained were filtered in Bioworks with the following filter 328 
criteria: ∆Cn > 0.08, Xcorr > 1.5 for charge state 2+, Xcorr > 3.3 for charge state 3+ and 329 
Xcorr > 3.5 for charge state 4+ (Peng et al., 2003). Only those proteins that showed a 330 
Bioworks Score factor (Sf) larger then 0.9 were considered. 331 
 332 
Detection of immunodominant protein candidates  333 
Following separation by 12% SDS-PAGE, proteins of purified GpSGHV particles were 334 
transferred to Immobilon-P membranes. Membranes were blocked overnight by 335 
incubation with 1% low fat milk and 0.05% Tween-20 in PBS (137 mM NaCL, 2.7 mM 336 
KCl, 10 mM Na2HPO4, and 1.76 mM KH2PO4 pH 7.4) at room temperature. Membranes 337 
were washed once with 0.2% low fat milk in PBS-tween-20 for 5 min, incubated with  338 
rabbit primary antibody (anti-GpSGHV; diluted 1/500, see below) at room temperature 339 
for 30 min, washed three times with PBS-Tween-20, and further incubated for 30 min in 340 
goat anti-rabbit IgG-Alkaline phosphatase conjugate (Promega) diluted 1:3000. Blots 341 
were washed three times with alkaline phosphatase buffer (0.1 M Tris-HCl, 5mm MgCl2, 342 
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pH 9.5) and stained with 1% of Nitro-Blue Tetrazolium Chloride/5-Bromo-4-Chloro-3’-343 
Indolyphosphate p-Toluidine Salt (NBT/BCIP) in alkaline phosphatase buffer. 344 
 345 
Selection of open reading frames, PCR amplification and gene cloning 346 
Candidate open reading frames (ORFs) for protein expression were selected based on the 347 
molecular masses of LC-MS/MS identified proteins and the immunoblot analyses. Viral 348 
DNA was extracted from purified virus as previously reported (Abd-Alla et al., 2007), 349 
and approximately 5 ng of the DNA was used as template. PCR amplifications were 350 
performed with HF Phusion Taq DNA polymerase (Finnzymes), using the reaction 351 
mixture recommended by the supplier. The primers were designed to amplify the 352 
hydrophilic regions of the selected ORFs (Supplementary Table S1) and were used at a 353 
final concentration of 0.2 mM. The PCR conditions were 98°C for 30 sec; 98ºC for 10s, 354 
59ºC for 20s, and 72ºC for 30 s/kbp for 25 to 30 cycles; and finally 72ºC for 5 min. The 355 
PCR products were individually inserted into pJET1.2/blunt cloning vector (CloneJETTM 356 
PCR Cloning kit, Fermentas). The resulting recombinant plasmids were purified with 357 
homemade GF/F columns as described in Borodina et al., (2003) and the inserts were 358 
sequenced to confirm the sequences. The inserted DNA fragments were re-cloned into 359 
pET28a(+) (Sambrook et al., 1989) at the multiple cloning site. 360 
 361 
 362 
GpSGHV proteins: expression, purification and production of antisera 363 
Escherichia coli BL21 (DE3) cells were transformed with the pET28-derived plasmids to 364 
express the cloned genes according to the pET system manual (Novagen). The bacteria 365 
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expressing the viral genes were sonicated in Laemmli sample buffer (Laemmli, 1970) and 366 
purified using preparative SDS-PAGE (Model 491 Prep Cell, Bio-Rad Laboratories) 367 
according to manufacturer’s instructions. Ten µl of each recombinant protein was 368 
analyzed on 12 % SDS-PAGE followed by silver staining according to standard 369 
protocols. The purity and quantity were verified with Coomassie Blue staining and with 370 
Western blotting, using specific immune serum directed against His-tag. To reduce the 371 
amount of SDS in the samples, each protein fraction was concentrated with 372 
CENTRIPREP® YM-10 centrifugal membranes (Amicon bioseparations).  373 
Antisera were prepared against the purified proteins (proteins encoded by ORF96 374 
and the C-terminal fragment of ORF10) by injecting rabbits with 0.4-0.8 mg of the 375 
recombinant protein emulsified in Freund incomplete adjuvant. Two booster injections 376 
were given at 2-week intervals. Another two antisera were prepared against the P74 377 
protein (ORF1) using the synthetic oligopeptides LYEHSKDEDGVYHRA-C (amino 378 
acids 114 to 128) and C-SEENKIASIDDKEQF (amino acids 612-626) (Pacific 379 
Immunology Corp, Ramona, CA 92065). Polyclonal antibody against the whole 380 
GpSGHV particles was collected from rabbit used for several months to feed tsetse flies 381 
in CIRAD, France. 382 
 383 
Electron microscopy and immunolocalization of authentic viral proteins 384 
Aliquots (5 µl) of GpSGHV virion suspension were adsorbed to carbon-coated and 385 
ionized nickel grids (400 mesh) for 5 min at room temperature and treated for negative 386 
staining with phosphotungstic acid or for immunogold labeling. For the latter the grids 387 
were then blocked with blocking buffer (5% bovine serum albumin, 5% normal serum, 388 
18 
 
0.1% cold water skin gelatin, 10 mM phosphate buffer, 150 mM NaCl, pH 7.4) for 30 389 
min, and incubated with primary antibody or pre-immune rabbit serum (1:20 dilution in 390 
incubation buffer) for 1.5 h  at room temperature. After incubation, and after several 391 
washes, the grids were incubated with goat anti-rabbit secondary antibody conjugated 392 
with gold particles (10 nm-diameter; 1:20 dilution in incubation buffer) for 45 min at 393 
room temperature. The grids were washed extensively with incubation buffer to remove 394 
excess salt, and negatively stained with 2% sodium phosphotungstate, (pH 6.5) for 5-10 395 
sec. The specimens examined with a transmission electron microscope (Jeol, JEM-1011, 396 
100 kV EM). 397 
 398 
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 Figure legends  552 
 553 
Figure 1: Purification of GpSGHV virions used for mass spectrometry analysis. Virions 554 
from hypertrophied salivary glands were purified by Nycodenz gradient centrifugation (A); 555 
the arrow indicates a single distinct band that was selected after centrifugation for 1 h at 556 
150,000 x g. Micrographs show a negatively-stained ultra-thin section (B) and a suspension 557 
of the isolated GpSGHV (C).  558 
 559 
Figure 2: SDS-PAGE analysis of Nycodenz-purified GpSGHV stained with Coomassie 560 
blue (A) and the relative locations of the 61 SGHV-encoded virion proteins identified by 561 
LC-MS-MS analysis (B). Adjacent numbers represent the different open reading frames 562 
(ORFs), that were detected in the seven gel sections (i to vii). The numbers in the 563 
parentheses represent the number of unique peptides used to identify the designated ORFs. 564 
 565 
Figure 3: Positioning of the 61 virion (structural) proteins encoded by GpSGHV on the 566 
genomic  map of GpSGHV (Abd-Alla et al., 2008). The arrows indicate the positions and 567 
the direction of transcription for the ORFs.  568 
 569 
Figure 4: Western blot analysis of purified GpSGHV using rabbit antiserum against the 570 
whole GpSGHV virion (dilution of 1: 500). The arrows indicate two bands (approximately 571 
130 kDa and 50 kDa) that reacted strongly with the rabbit antiserum. Budded virus (BV) 572 
and occlusion derived virus (ODV) particles from the baculovirus Autographa californica 573 
multiple nucleopolyhedrovirus (AcMNPV) were used as negative control. 574 
 575 
 Figure 5: Detection of ORF10 and ORF96 with specific antibodies in SGHV virions.  576 
A. Western blot analysis with specific rabbit antibodies against proteins encoded by 577 
GpSGHV ORF96 and ORF10 (diluted 1: 500). Shown in the figure are Nycodenz-purified 578 
GpSGHV virions (lanes 1), a homogenate of hypertrophied (lanes 2), and non-infected 579 
(lanes 3) tsetse fly salivary gland cells. B. Electron micrographs of GpSGHV virions using 580 
pre-immune rabbit antiserum (A) and rabbit antiserum against the C-terminal fragment of 581 
the ORF10 (B). The secondary antibody was goat anti-rabbit IgG conjugated with 10 nm of 582 
gold (Aurion). 583 
 584 
Table 1: The GpSGHV virion proteins identified by mass spectrometry in order of 
descending molecular mass (511 to 10 kDa)*. 
ORF GeneBank Accession No. 
Predicted mol. 
mass 
in kDa 
Protein 
coverage 
in % amino 
acids 
No. of 
peptides 
identified 
pI Characteristics of deduced proteins 
Conserved 
domain(s) 
62 YP_001687010  511.81 1.8 7 4.70   
45 YP_001686993 200.98 4.1 7 5.94   
38 YP_001686986 136.46 42.20 130 5.91  TM 
10 YP_001686958 126.96 81 305 5.60 Major protein 
 
Coiled-coil 
region 
40 YP_001686988 104.065 3.9 3 9.16   
83 YP_001687031 81.54 13 9 5.59 (Md013)  
1 YP_001686949 81.35 13.8 12 4.73 p74 (bac) (Md039) TM 
104 YP_001687052 77.84 7 6 7.30  TM, coiled-
coil region 
88 YP_001687036 77.71 15.3 11 7.36   
102 YP_001687050  76.07 12.4 9 5.02 PIF-1 (bac) TM, SP 
71 YP_001687019 71.95 2 1 6.66 (Md090)  
86 YP_001687034 70.13 29.4 28 7.76   
64 YP_001687012 69.98 43.7 42 8.95 ATPase/Helicase  
(Md097) 
 
108 YP_001687056 63.90 30.5 15 5.34 Cell division 48-like 
protein  (Md033) 
 
46 YP_001686994 61.50 37.7 24 6.48 (Md084)  
107 YP_001687055  59.53 45.1 31 5.39 Cell division 48-like 
protein  (Md33) 
 
61 YP_001687009 57.40 38.3 14 8.68   
106 YP_001687054 55.05 31.3 15 5.31  Coiled-coil 
region 
27 YP_001686975 53.03 5.5 3 6.12 Chitinase Chit1  
precursor-like protein  
TM 
70 YP_001687018             50.89 23.9 13 9.44   
41 YP_001686989 48.74 24.9 15 6.78   
140 YP_001687088 48.41 10 5 9.26  Coiled-coil 
region 
47 YP_001686995 47.16 61.9 98 4.47   
97 YP_001687045 44.37 62.9 83 8.61 (Md025) TM 
96 YP_001687044 43.50 77.2 170 6.57 Major   protein 
(Md025) 
TM, SP 
44 YP_001686992 42.81 20.3 8 8.84  SP 
34 YP_001686982 41.15 7.7 3 9.13   
7 YP_001686955 41.02 15.3 5 9.14   
33 YP_001686981 40.98 10.3 3 9.51   
53 YP_001687001 40.21 27.8 11 5.05 PIF-2 (bac)  
154 YP_001687102 40.07 8 4 7.50 (Md071)  
2 YP_001686950 38.64 31.8 17 8.99   
93 YP_001687041 38.51 57.8 39 9.53 (Md022) TM 
39 YP_001686987 37.64 4.8 1 4.47  TM, SP 
52 YP_001687000 36.67 6.5 7 8.63   
105 YP_001687053 34.75 7.9 2 9.82  Coiled-coil 
region 
31 YP_001686979 33.58 19.3 5 9.62   
113 YP_001687061 33.10 34.5 11 8.76   
50 YP_001686998 32.72 29.2 45 6.33 (Md086)  
94 YP_001687042 32.68 57.5 34 9.28   
72 YP_001687020 31.75 27.9 7 8.32 (Md102) TM 
8 YP_001686956 31.58 31.4 9 9.61   
91 YP_001687039 31.47 7.1 2 7.96  TM, SP 
67 YP_001687015 30.99 47.1 30 4.55   
69 YP_001687017 30.89 41.9 49 7.41  TM, SP 
32 YP_001686980 30.08 13.9 3 4.90   
ORF GeneBank Accession No. 
Predicted mol. 
mass 
in kDa 
Protein 
coverage 
in % amino 
acids 
No. of 
peptides 
identified 
pI Characteristics of deduced proteins 
Conserved 
domain(s) 
85 YP_001687033 30.07 40 15 9.29   
78 YP_001687026 27.83 9.3 3 7.93  TM 
146 YP_001687094 26.67 9 2 9.50   
84 YP_001687032 25.75 28.8 8 9.37   
76 YP_001687024 24.39 9.5 2 4.34 PIF-3 (bac) TM 
110 YP_001687058 23.62 27.9 4 7.71 mp-nase (bac) TM 
112 YP_001687060 19.05 19.2 8 4.64  TM 
82 YP_001687030 18.67 23.3 3 9.84   
43 YP_001686991 16.89 69.4 28 9.91 (Md072) TM 
30 YP_001686978 15.91 10.5 1 10.17   
36 YP_001686984 13.79 12.2 2 5.77 Thymidylate 
synthase (nima) 
 
98 YP_001687046 13.52 51.3 10 10.67   
68 YP_001687016 12.64 37 6 7.63   
101 YP_001687049 12.33 62.3 37 9.56  TM, SP 
49 YP_001686997 10.00 12.2 1 8.17   
*pI is isoelectric point, SP is signal peptide, TM is transmembrane domain; homologs with 
MdSGHV (Md), baculovirus (bac) and nimavirus (nima) and ascoviruses are indicated. 
 
 
 
Table 2: Proteins represented in the proteome of GpSGHV with homolog genes in MdSGHV 
genome. The MdSGHV homologs that were also identified in the MdSGHV proteome are in 
bold*.  
 
GpSGHV ORF MdSGHV ORF  GpSGHV ORF MdSGHV ORF 
ORF Length ORF Length  ORF Length ORF Length 
1 (p74) 696 39 (p74) 707  72 269 102 257 
30 133  76 (pif-3) 211 106 (pif-3) 174 
31 285 
82 359 
 78 236 108 205 
32 259  82 159 4 131 
33 348 
74 698 
 83 694 13 644 
40 901 70 967  86 1779 16 1500 
41 413 55 416  88 652 17 553 
43 144 72 136  93 329 22 343 
44 359 73 390  96 381 
45 1728 83 1780  97 394 
25 376 
46 533 84 509  102 (pif-1) 652 29 (pif-1) 644 
50 291 86 381  104 660 30 692 
53 (pif-2) 360 89 (pif-2) 379  107 521 
61 494 100 455  108 545 
33 497 
64 595 97 595  110 201 36 196 
68 327 94 336  154 338 71 333 
71 608 90 672      
 
* MdSGHV proteome data (Garcia et al., 2008; ibid, 2009). Four GpSGHV ORFs share a 
homolog in MdSGHV. ORF length is given in amino acids. 
 





